Status:

COMPLETED

Outcomes of Patients With COVID-19 in the Intensive Care Unit

Lead Sponsor:

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Conditions:

Coronavirus Infections

COVID-19

Eligibility:

All Genders

18+ years

Brief Summary

The objective of this study is to evaluate the clinical characteristics and outcomes of critically ill patients with COVID-19 admitted to the intensive care unit. A Multicenter Observational Study.

Detailed Description

As of 23 March 2020, a cumulative total of 332,930 confirmed cases of coronavirus disease 2019 (COVID-19) were reported in 189 countries and territories worldwide. As of this time, there had been 367 ...

Eligibility Criteria

Inclusion

  • Confirmed case: Critically ill patient who meets the operational definition of a suspected case and who has a confirmed diagnosis by the National Network of Public Health Laboratories recognized by the Institute of Epidemiological Diagnosis and Reference (Indre) (Mexico).

Exclusion

  • If a negative for SARS-CoV-2 result is obtained from a critically ill patient with a high index of suspicion for COVID-19 virus infection.
  • Patients who had participated in another observational study in the last 30 days prior to inclusion.

Key Trial Info

Start Date :

April 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 4 2020

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT04336345

Start Date

April 1 2020

End Date

June 4 2020

Last Update

November 10 2020

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

Mexico City, Mexico, 14000

2

All centres from Mexico willing to contribute are Welcome.

México, Mexico

Outcomes of Patients With COVID-19 in the Intensive Care Unit | DecenTrialz